INTRODUCTION
============

Glomerular filtration rate (GFR) is considered the best overall index of kidney function. It is dependent on age, gender, ethnicity, body composition and diet \[[@sfy022-B1]\] as well as nephron endowment \[[@sfy022-B2]\]. GFR is determined by the measured clearance of certain exogenous markers or endogenous waste products. In everyday practice, clinicians usually rely on estimated GFR (eGFR) calculated from a single serum marker measurement, mostly creatinine. However, such estimates have several limitations. Estimating equations are valid only in steady-state conditions. Moreover, analytical variation of serum creatinine measurements (2% for enzymatic assays), variation in tubular secretion and dependency on muscle mass \[[@sfy022-B3]\] should be factored in.

Often ignored, GFR is not constant, as the kidneys do not continuously function at maximum filtration capacity \[[@sfy022-B4]\]. It is estimated that in healthy subjects, kidneys usually operate at ∼75% of their maximal GFR. Renal function is influenced by diurnal cycles \[[@sfy022-B5]\] and is stimulated by protein-containing meals. Thus, single-point assessments of renal function ignore varying rates of glomerular filtration, as kidneys are capable of adjusting their performance to haemodynamic and metabolic demands.

In 1930, Verney mentioned the reserve forces of the kidney \[[@sfy022-B6]\]. In analogy with myocardial and pulmonary function, a redundant or dormant renal reserve was hypothesized, intended to cope with extraordinary haemodynamic and metabolic demands. Fifty years later, Bosch called this the renal functional reserve (RFR), defined as the difference between the baseline GFR and the stimulated GFR, measured 2 h after a protein meal \[[@sfy022-B7]\].

Over the years, enthusiasm for the RFR concept abated \[[@sfy022-B8]\], until Ronco and colleagues \[[@sfy022-B4], [@sfy022-B13]\] and Molitoris \[[@sfy022-B16]\] recently revived interest in this concept. They postulate that diminished RFR contributes to the susceptibility for recurrent acute kidney injury (AKI). These authors argue that evaluation of the degree of functional recovery post-AKI is not only clouded by the loss of muscle mass but also by stimulated single-nephron GFR to compensate for nephron loss. Testing the renal functional response in these recovered patients could possibly unveil this undetected loss of functional units and could identify patients at risk for progression to chronic kidney disease (CKD). This hypothesis was discussed and reviewed at the Fifth International Conference of the French Society of Intensive Care \[[@sfy022-B17], [@sfy022-B18]\].

Additionally, a deficit in RFR has been incriminated in pregnancy-related kidney disease \[[@sfy022-B19]\]. Further, study of the diagnostic and prognostic utility of RFR has been mentioned in the roadmap for global kidney health 2017, issued by the International Society of Nephrology \[[@sfy022-B20]\]. Finally, the promotion of high-protein diets to lose weight stimulated renewed attention to the postprandial behaviour of the GFR.

Reviewing the literature on RFR is impeded by a myriad of definitions and stimulatory tests. This article aims to propose a synthesizing lexicon and tries to offer a variety of protocols for future directions of research.

LEXICON
=======

The RFR (also referred to as renal reserve capacity) is defined as the difference between the stimulated GFR and the baseline GFR. This difference can be expressed in absolute terms (mL/min) or in relative terms (percentage of increment relative to the baseline GFR). Although a straightforward and simple definition at first sight, terminologies and definitions are quite confusing. [Table 1](#sfy022-T1){ref-type="table"} proposes a revised nomenclature in the context of renal functional testing. The expression of RFR should be replaced by renal functional response. Table 1.Suggested terminology and alternatives in the context of a renal stimulation testUnstimulated GFRRandom GFRStimulated GFRUnstressed GFRUncontrolled GFRStressed GFRBasal GFRActual GFRPeak GFRBaseline GFRReference GFRMaximal or maximized GFRResting GFRMaximal filtration capacityMinimal GFR[^1]

The baseline or basal GFR is sometimes referred to as unstimulated GFR (as opposed to stimulated GFR) or unstressed GFR (to better differentiate it from the GFR in stressed circumstances) and finally resting GFR. While the resting GFR is the lowest normal GFR, it is not identical to the baseline GFR used in the context of AKI, which is usually defined as the best or highest GFR preceding an AKI episode \[[@sfy022-B17], [@sfy022-B21]\].

To maximally guarantee an unstimulated (lowest) GFR, patients are often instructed to adhere to a low-protein or vegetarian diet in preparation for a renal stimulation test. If the person is not instructed to do so, the test results (actual GFR and maximal increase) should be interpreted in the light of the usual protein intake of the subject. This can be derived from the urea nitrogen level in timed urine collection. Coincidentally, patients with CKD often follow a low-protein diet. This increases the value of a stimulatory test.

The stimulated or stressed GFR is the measured GFR following a stimulus, including an oral protein load, an intravenous amino acid (AA) solution, a glucagon infusion or a dopamine drip \[[@sfy022-B22]\]. Rodríguez-Iturbe *et al.* \[[@sfy022-B23]\] defined a tubular stress test, describing the tubular secretion of intravenously injected creatinine. Regretfully, a creatinine solution marketed for intravenous use in human experiments is currently not available (personal inquiry). As creatinine is readily absorbed by the gastrointestinal tract, an oral creatinine load is safer and might result in a comparable tubular challenge \[[@sfy022-B24]\]. Recently a furosemide stress test was applied to patients with progressive AKI, discriminating recovery from progression \[[@sfy022-B25]\]. Thus renal stimuli are either of a metabolic or haemodynamic nature. A protein meal, when composed of cooked meat, challenges the kidney with both AA and creatinine. This stimulus can be considered a combination of both a metabolic and a tubular stimulus.

Descriptions of the numerous alternative tubular challenges (sodium, potassium, phosphorus, acid, water deprivation and water loading) is beyond the scope of this review.

After stimulation and in healthy subjects, the GFR can reach 180--200 mL/min. Some authors refer to GFR in this range as hyperfiltration. Cachat *et al.* \[[@sfy022-B26]\] reviewed the literature in 2015 and Tonneijck *et al.* \[[@sfy022-B27]\] recently described the mechanisms of diabetic hyperfiltration. These authors correctly differentiate between whole kidney function as opposed to single-nephron function. On a single-nephron level, hyperfiltration is assumed when the intraglomerular pressure is elevated, causing albuminuria and in the long-term leading to progressive glomerulosclerosis. Single-nephron hyperfiltration does not automatically translate into whole-kidney hyperfiltration, quite the opposite: glomerular hyperfiltration is often intended to preserve a waning whole-kidney GFR in the face of a diminishing nephron number \[[@sfy022-B28]\]. More recently, high GFR values were also noted in septic intensive care unit (ICU) and post-operative patients. We advocate the use of augmented renal clearance for seemingly physiological adaptations and the use of stimulated GFR in the context of RFR.

PHYSIOLOGY OF METABOLIC RENAL STIMULATION
=========================================

For a more extensive overview of the functional compensation after a protein meal, we refer the reader to excellent reviews by Gabbai \[[@sfy022-B29]\], Bankir *et al.* \[[@sfy022-B30]\], Helal *et al.* \[[@sfy022-B31]\], King and Levey \[[@sfy022-B1]\] and Premen \[[@sfy022-B32]\].

Any metabolic stimulus triggers the kidneys to increase the GFR primarily by reducing the overall renal vascular resistance (RVR) and inducing a postprandial renal hyperaemia. This increase of the renal blood flow results from systemic mediators as well as paracrine factors, both acting on the whole kidney level as on the single-nephron GFR. Initially, recruitment of quiescent glomeruli in ill-perfused regions was hypothesized, hence the term 'renal functional reserve' \[[@sfy022-B7], [@sfy022-B33]\]. Later it was concluded that the increased GFR results from a higher filtration effort of all single nephrons, almost exclusively attributed to a higher effective renal plasma flow (ERPF).

The feed-forward stimulus after a protein load or an increase in AA plasma levels originates from the pancreas and the liver \[[@sfy022-B30]\]. A higher ratio of glucagon to insulin stimulates the liver in favour of nitrogen handling and helps the kidneys in the disposal of urea. The hepatic production of cyclic adenosine monophosphate (cAMP) operates as a second messenger. On the single-nephron level, glucagon and cAMP cooperate to reduce the tubular solute concentration at the macula densa. In this way, the tubuloglomerular feedback is downregulated. As a result, vasodilation of the pre-glomerular arteries and arterioles induces an increase in the single-nephron GFR. Intrinsic renal autoregulation with nitric oxide, vasodilating prostaglandins and kinins is responsible for this action. Inhibition of renal autocrine prostaglandin synthesis with indomethacin counteracts the vasodilatory effects of AAs. The hypothalamic--hypophyseal axis contributes to this process. Vasopressin or the antidiuretic hormone (ADH) is also active in stimulating the GFR after a protein meal. Together with glucagon, this hormone helps in the processing of protein metabolites. The role of growth hormone seems of less importance, as a protein meal equally elicits a functional renal response in growth hormone--deficient patients \[[@sfy022-B34], [@sfy022-B35]\].

In the long term, the afferent arteriole is evidently the weak spot in these consecutive events, as this site harbours the first signs of hypertensive hyalinosis, impeding maximal relaxation \[[@sfy022-B36]\]. Arterial stiffness proved to be an independent predictor of adaptive glomerular hyperfiltration after kidney donation \[[@sfy022-B37]\]. If the ERPF is not able to keep pace with the increased demands, the efferent vasoconstriction gradually prevails, leading to a higher intraglomerular pressure and filtration fraction (FF). This additive mechanism, triggered by the renin--angiotensin system with thromboxane A2 and endothelin-1 as cofactors, leads to a cascade of negative events. In the long run, a higher FF might lead to glomerular as well as tubular injury and a loss of nephrons. Treatment with an angiotensin-converting enzyme (ACE) inhibitor has been shown to restore the GFR response after a protein stimulation \[[@sfy022-B38]\].

METHODOLOGY OF RENAL STIMULATION TESTS
======================================

[Table 2](#sfy022-T2){ref-type="table"} provides an overview of the chronology and methodology of a renal stimulation test. The numerous stimuli and modes of GFR measurements are described in the following paragraph. Table 2.How to perform a renal stimulation test?VariablesPreparatory phase: instruction and informed consentTest day: Part 1, measuring unstimulated GFRTest day: Part 2, stimulusTest day: Part 3, measuring stimulated GFRLocationHomeHospital: recumbent positionDuration1 day: starting urine collection2--3 days: when CACrC is opted10 days: when a low-protein diet is advised2--4 h30--60 min to cover ingestion and digestion2--4 hDietDiet 1: habitual diet until the night before RFR testingFasting for at least 8 hDiet 2: controlled low-protein diet for at least 10 days before RFRFasting for at least 8 hFluidsDrinking according to thirstDrinking is stimulated: 10--20 mL/kg at startDrinking in equal amounts to match diuresisDrinking in equal amounts to match diuresisPOStart cimetidine (when CACrC is chosen) according to the Hilbrands protocolStimulus option 1: 1 g/kg protein offered as cooked meat (containing creatinine)Stop NSAID, preferentially pause ACE i or angiotensin receptor blockerStimulus option 2: 1 g/kg protein offered as egg whites or a commercial protein solution (not containing creatinine)IVIntroduce two separate IV linesStimulus option 3: a 10% IV AA solution at a rate of 4 mL/kg/h during 3 hStimulus option 4: IV dopamine at a rate of 2 µg/kg/min (can be combined with stimulus 3)Stimulus option 5: IV glucagon at a rate of 10--20 ng/kg/min during 1 hClinical examWeight, height, hydration status, blood pressureBlood pressure and heart rate at regular intervalsBlood as well as urine samples in combination with timed urine collections24-h urine collection for reference creatinine clearance, sodium excretion and urea nitrogen appearanceGFR option 1: plasma or urinary clearance of an exogenous markerUrine collections and samples: every 30--60 min bracketed with serum samplesGFR option 2: urinary CrC (with or without cimetidine correction)Urine collections and samples: every 30--60 minutes bracketed with serum samplesUrine collections and samples every 30--60 min bracketed with serum samplesResultUnstimulated GFR orCrC:mean of at least three measurementsStimulated GFR orStimulated CrC:highest of at least three measurements[^2]

Measurement of unstimulated GFR
-------------------------------

Several factors may influence the unstimulated GFR. First, hydration status \[[@sfy022-B39]\] is a very important confounding variable. Spinelli *et al.* \[[@sfy022-B40]\] advise the use of bio-impedance measurements to identify dehydrated subjects. For this reason, most protocols adopt a strict oral hydration policy, starting with 10--20 mL/kg plain water and replacing each voided urine sample with an equal amount of oral fluids. Hypovolaemia also blunts the renal response after stimulation \[[@sfy022-B38]\]. Second, the body must remain in the fasting state for at least 8 h (overnight fasting). A low-protein or vegetarian diet for 10 days preceding the test is advised by some authors to ascertain a true unstimulated GFR. Doubt remains if this interval succeeds in normalizing glomerular hypertrophy caused by a chronically high-protein diet. If the investigator does not advocate this preparatory phase, habitual protein intake can be estimated from urea nitrogen in a 24-h urine collection \[[@sfy022-B41]\] and the extent of GFR stimulation must be interpreted with this knowledge. Finally, besides a thorough non-pharmacological preparation, some drugs must be paused, as they interfere with renal vascular adaptation. These include non-steroidal anti-inflammatory drugs (NSAIDs) \[[@sfy022-B42]\], ACE inhibitors and angiotensin receptor blockers.

Selecting the proper stimulus
-----------------------------

Measuring the stimulated GFR requires maximal recruitment of the so-called reserve GFR. Several approaches have been advocated, which---broadly speaking---can be divided into haemodynamic and metabolic stimuli.

In humans, a significant increase of the GFR has been described with glucagon infusions at a rate of 10--20 ng/kg/min. More frequently, dopamine is used. This vasoactive drug augments the ERPF and hence the GFR without affecting cardiac output or systemic vascular resistance. The FF usually drops slightly when dopamine is infused at a dose of 2.0 µg/kg/min. This is the result of afferent and preferentially efferent arteriolar dilation \[[@sfy022-B43]\]. At the single-nephron level, the increased filtration seems totally attributable to higher plasma flow in combination with lower transcapillary pressure. Sometimes dopamine is the only renal stimulus used, for instance, in a dopamine-induced glomerular response test \[[@sfy022-B44]\].

Dopamine provocation may be combined with a metabolic stimulus. When combined with an AA infusion, the effects are additive \[[@sfy022-B45]\]. During the AA infusion, ERPF and GFR increase proportionally with a predominant afferent arteriolar dilation resulting in a constant FF. The composition of the AA solution depends on local availability, but gluconeogenic AA should be present \[[@sfy022-B46]\], whereas branched-chain AAs do not alter GFR or FF \[[@sfy022-B47]\]. The infusion rates reported in the literature are disparate. The AA infusion can begin the night before the test day, but the GFR response is already present after a 1- or 2-h infusion time. A dose--response curve for AA stimulus was constructed by Giordano *et al.* \[[@sfy022-B48]\]. Within the physiological range, incremental AA concentrations cause a stepwise increase in the GFR, whereas this effect levels off in the pharmacological range.

The administration of a single AA to elicit a change in GFR is also reported. Arginine \[[@sfy022-B49], [@sfy022-B50]\] and glycine have been used, each acting via different pathways. Arginine causes systemic and renal vasodilation, while glycine operates via the *N*-methyl-D-aspartate glutamate receptor (NMDA-R) \[[@sfy022-B29]\]. This receptor is localized in the proximal tubule and functions as a calcium channel, causing local vasodilation.

A more natural approach is to stimulate the GFR by a protein meal. This short-term oral protein loading should consist of at least 1 g/kg of protein \[[@sfy022-B51]\]. Rodríguez-Iturbe *et al.* \[[@sfy022-B52]\] studied three quantities of protein meals: 1.3, 1.1 and 0.55 g/kg. The filtration fraction rose significantly with the moderate and large protein load but not with the lower protein load.

Animal proteins are preferred, so most centres prepare a cooked beef hamburger. Red meat, however, contains 3.5--5 mg/g creatine. By cooking, a non-metabolic conversion of creatine to creatinine occurs \[[@sfy022-B53]\]. This metabolite is easily absorbed and the rising serum levels result in increased tubular secretion until the tubular transport maximum is reached \[[@sfy022-B54]\]. Accordingly, the more pronounced response (after a protein challenge) of creatinine clearance (CrC) compared with inulin clearance is due to a higher input and increased tubular secretion of creatinine.

Alternatives for animal protein are dairy products and egg-white proteins. These are more practical in paediatric subjects \[[@sfy022-B55]\]. Vegetable proteins, for instance soy products or bean curd, are less effective in stimulating the GFR \[[@sfy022-B56]\]. Many reasons for this difference have been postulated, including a different AA mixture, less sulphur-containing AA, less oxidative stress or acid load, lower maximal AA serum levels, faster internalization in the cells due to a different insulin/glucagon surge, less sodium and more potassium content. An elaborate description of the renal benefits attributed to a vegetarian diet is beyond the scope of this article. The reader is referred to excellent reviews by Kalantar-Zadeh *et al.* \[[@sfy022-B57]\] and Snelson and Fouque \[[@sfy022-B58]\].

The renal response after a haemodynamic stimulus is immediate while the maximal effect of a metabolic stimulus is noted after 1--3 h. Recent evidence shows that in obese non-diabetic subjects, the maximal rise in GFR after a protein stimulus is postponed \[[@sfy022-B59]\].

Over the years, no major side effects of renal stimulation tests have been observed. In the different studies, blood pressure and heart rate were carefully monitored, especially when dopamine was used as a stimulating agent. After the stimulus has waned renal function returns to its unstimulated state. Intravenous perfusion of a hyperosmolar AA solution has been found to cause local pain and phlebitis. No increase in urinary neutrophil gelatinase-associated lipocalin or proteinuria has been documented in the protein stimulation experiments performed by Sharma *et al.* \[[@sfy022-B51]\]. N-acetyl glucosaminidase (NAG) has been studied in immunoglobulin A nephropathy (IgAN) during RFR testing \[[@sfy022-B60]\], but the serial documentation of damage biomarkers, including albuminuria, remains largely unexplored.

Measuring GFR during renal stimulation tests
--------------------------------------------

The Achilles heel of renal function testing is the method used for GFR determination \[[@sfy022-B61]\]. Urinary inulin clearance remains the most extensively reported method in renal stimulation tests. This classic mode of GFR measurement is often combined with para-aminohippuric acid (PAH) clearance to document the ERPF. Delanaye *et al.* \[[@sfy022-B62]\] delineates the difficulties of this technique, including costs, variances in lab techniques and availability. Zitta *et al.* \[[@sfy022-B44]\] succeeded in studying GFR behaviour after AA infusion via the plasma kinetics of sinistrin and hippurate supplied to a two-compartment computer model. The advantage of this technique is the elimination of urine collections.

The easiest alternative for the use of inulin is to monitor urinary CrC by timed urine collections (30 or 60 min), considering known caveats when using this biomarker. At least three clearance calculations are advised. The CrC overestimates true GFR because of additive tubular secretion, leading to a mean bias of 14 mL/min or 25% \[[@sfy022-B63]\]. The overestimation depends on baseline kidney function. However, when subjects are asked to adhere to a low-protein diet of 0.5 g/kg/day, calculated CrCs are similar to inulin clearance \[[@sfy022-B64], [@sfy022-B65]\]. When urinary CrC is used not only as a GFR estimator but also to track accessory tubular secretion, the intake of drugs that inhibit the tubular secretion of creatinine must be avoided (e.g. trimethoprim--sulfamethoxazole, cimetidine and possibly fenofibrate). On the other hand, when the investigator wants to capture solely the dynamics of glomerular filtration, tubular secretion of creatinine can be blocked by cimetidine. This results in the cimetidine-aided CrC (CACrC). In the publication by Hilbrands *et al.* \[[@sfy022-B66]\], cimetidine was started 1--4 days prior to the GFR stimulus according to a dosing protocol determined by the actual renal function.

Irrespective of the methodology, investigators must ascertain complete voiding or resort to placing a bladder catheter (mostly done in children, which increases the invasiveness of the test).

We do not advocate GFR estimating formulas (Chronic Kidney Disease Epidemiology Collaboration formula or Cockcroft--Gault formula\] to document the renal functional response. Some authors propose cystatin C measurements \[[@sfy022-B67], [@sfy022-B68]\]. The kinetics of this functional biomarker have been tested after protein meals, with conflicting results \[[@sfy022-B69], [@sfy022-B70]\].

Alternative possibilities for measuring the GFR before and after a stimulus are urinary or plasma clearances of isotopes, e.g. ^51^Cr-labeled ethylenediaminetetra-acetic acid (Cr-EDTA), ^125^I-labeled iothalamate \[[@sfy022-B45]\] and ^99m^Tc-labeled diethylenetriaminepenta-acetic acid (Tc-DTPA) (see [Tables 4](#sfy022-T4){ref-type="table"} and [5](#sfy022-T5){ref-type="table"} for references). Most protocols choose the urinary clearance of a subcutaneously injected or continuously infused radioisotope. Alternatively, calculation of the GFR by decaying plasma levels after an intravenous bolus can be performed. However, this technique requires the investigator to invite the test person on two separate days, one for an unstimulated GFR test and one for a stimulated GFR test. Other drawbacks are the exposure to radiation and the additional costs. Recently an elegant technique of urinary clearance of iohexol was tested in an ICU population with varying GFRs \[[@sfy022-B71]\]. The protocol describes a bolus injection followed by a continuous infusion of a low dose of iohexol combined with regular plasma and urine sampling. This technique seems applicable in renal function testing. Table 4.Current experience with renal stimulation testing in subjects without kidney disease (for reference list, see [Supplementary material](#sup1){ref-type="supplementary-material"})Type of stimulusType of GFR measurementConfounding variablesReferenceNumberDopamineAmino acidsProtein mealCreatinine IVUrinary inulin (+ PAH) clearanceUrinary CrCExogenous markerSummary of the resultsBosch 1983^1^5: normal protein diet 8: vegetarian dietXXXGFR reached a maximal level of 171 ± 7.7 mL/min after 150 min. In patients with reduced number of nephrons, RFR may be diminished or absentGraf 1983^2^5 receiving parenteral nutritionXXEndogenous CrC increases during infusion of AABosch 1984^3^16XXCrC increases from 123 ± 13 to 157 ± 13 mL/minRodriguez-Iturbe 1985^4^44XXCrC increases from 108.5 ± 6.45 to 161.5 ± 9.39 mL/minter Wee 1986^5^9XXIOTH 1Infusion of AA and dopamine show additive effects: dopamine lowers FF, while during AA infusion the FF remains unchangedHostetter 1986^6^10XXGFR increases from 101 ± 7 to 114 ± 6 mL/min. RVR decreasesCastellino 1986^7^13XXGFR increases from 107 ± 5 to 128 ± 4 mL/min. Somatostatine blocks this increaseBosch 1986^8^7XXGFR increases from 122 ± 10 to 151 ± 15 mL/minSolling 1986^9^Healthy male physicians and studentsXIOTH 1Eight subjects received a meat meal while seven were challenged with an AA infusion. GFR and RPF increased and FF as well as albumin excretion remained unchangedMansy 1987^10^XXXSame increase of CrC after AA, 80 g meat and 80 g milk proteinRodriguez-Iturbe 1988^11^37XXSubjects were given, three quantities of protein load:mild protein load, 0.55 g/kg;moderate protein load, 1.08 g/kg;high protein load, 1.35 g/kg.The effect on the GFR was incremental: the largest increase of GFR was observed when a high protein load was served. To accomplish this GFR increase, the filtration fraction was significantly increasedRodriguez-Iturbe 1988^12^10XXA protein meal and not a carbohydrate meal stimulates the CrC and is associated with a parallel increase (doubling) in plasma immunoreactive ANFHirschberg 1988^13^12 subjects(Glucagon)X (Arg)XGlucagon and IV infusion of arginine induce an increase in GFR that is blunted by NSAIDsCastellino 1988^14^18XXThe renal haemodynamic response following AA infusion is dependent on insulin/glucagon/growth hormone replacement and can be blocked by somatostatinLaville 1989^15^9XXXSimultaneous measurements of GFR and CrC showed a peak in GFR after 127 min and a maximal CrC after 189 min. This was caused by a subsequent increase of tubular secretion of creatinine (contributing 15%)Olsen 1990^16^12 volunteersXEDTA 1AA increased GFR by a primary effect on renal haemodynamics or, less likely, by reducing the signal to the TGF. The increase in proximal tubular outflow was compensated for in the distal tubulesTam 1990^17^12 healthy medical studentsXXThree protein meals were offered and compared with a control meal. Regardless of the protein content, an increase in CrC is observedBraendle 1990^18^10XXOral protein concentrate and an oral mixture of AA induce a similar increase in GFRWada 1991^19^7 normal subjects tested twice with a different AA compositoinXXBranched-chain AA induces no increase of CrC, while a mixture of AA elicits the expected functional response. Only the infusion of a mixture of AA is accompanied by an increase in serum glucagon levelsCirillo 1998^20^25 healthy adultsXXGFR and urinary sodium excretion increase over baseline after a protein meal of 2 g/kg. A net decrease in sodium balance is observedLuipold 2000^21^12 volunteersXXAA infusion increases GFR and RPF. Pretreatment with domperidone marginally influences while sulpiride completely blocks the renal response. Sulpiride acts as a centrally and peripherally acting D~2~-like receptor antagonistBarai 2008^22^109 kidney donor candidatesXDTPA 1Lower mean GFR in healthy adult Indians than whites. No difference between sexes. Similar increment of the GFR after AA stimulation: 27.3  ± 10.01%Bird 2008^23^20XEDTA 2Comparison of iohexol with Cr-EDTA. Fasting and non-fasting. BSA versus ECV. The only significant increase of GFR was observed when GFR/BSA was consideredSharma 2016^24^18XXSimilar increase of CrC after 1 and 2 g/kg protein load and 1 g/kg protein powder. No appearance of urinary NGALRodenbach 2017^25^18XX with cimetidineIOH 1Protein loading stimulates iohexol clearance and CACrC after a beef-or milk-based meal. Cystatin C eGFR changes are smallerAgeFliser 1993^26^10, median age 70 years (up to 80 years)XXLower GFR and ERPF in elderly. The median percent increase (17%) was not different from younger controls. Higher RVR and FF in the elderlyBöhler 199312 non-renal patients ages 60--80 yearsXXBaseline GFR is lower in the elderly compared with young adults. However, RFR is well maintained in elderly human subjectsPecly 1999^27^13: 20--39 years13: 40--5911: 60--68XXAgeing decreases the increment of CrC. Increased bradykinin seems responsible for the GFR adaptationFuiano 2001^28^10 young11: 65--76 years15 young donors11 older donorsXXXIn older subjects, GFR is lower. After combined stimulus, a smaller increase was seen in older subjects. More arteriosclerosis and interstitial fibrosis in older patients.Esposito 2007^29^6 (25--37 years)6 (44--74 years)7 (81--96 years)XXXGFR and RPF were slightly reduced in elderly individuals, which resulted in increased FF. In the elderly as opposed to young and middle-aged subjects, neither GFR nor RPF increased after maximal stimulationMusso 2011^30^5: 20--40 years6: 64--74 years5: \> 74 yearsXX with cimetidineRenal functional response was present in all age groups. Its magnitude was significantly higher in healthy compared with older subjectsGenderNo dataEthnicityNo dataDiet \[low protein (LP), normal protein (NP), high protein (HP)\]Bosch 1984^3^10 (LP = 0.7--0.8 g/kg/d, NP 1.0--1.5 g/kg/d)XXCrC on low protein (LP) diet is lower: 97 ± 34 versus 109 ± 37 mL/min. Peak GFR is similar at 122 ± 45 mL/minCastellino^7^6 (LP= 40 g/d, NP 1.2--1.5 g/kg/d)XXGFR is lower on LP diet. Increment after stimulus is equalViberti 1987^31^6 (LP: 43 g/d, NP: 75 g/d)XXGFR is lower on LP diet: more relative increment but not reaching peak GFR on normal protein diet. Unchanged FFKontessis 1990^32^17 healthy subjects (3 weeks vegetarian versus animal protein)XXGFR is lower after a 3-week course of vegetarian protein. Soy proteins induce less GFR increase than meat proteins while serum AA levels are comparable. A meal containing animal protein induces a higher and more sustained increase in glucagon levelsNakamura 1993^33^6 healthy females and 6 type 2 diabeticsXIOTH 1Comparison with 0.7 g/kg tuna fish and the same or double amount of boiled egg white. GFR increases only after ingestion of tuna fish both in normal controls and diabetics. Only AA Gly and Ala rose differently after this mealNakamura 1989^34^11 healthy20 diabeticsXXComparison with 1.0 g/kg tuna fish versus bean curd. Vegetable protein could not induce an increase of the CrC in healthy subjects or in diabetics.Nakamura 1990^35^10 healthy volunteers6 type 2 diabeticsXXComparison with 0.7 g/kg tuna fish versus boiled egg white, cheese of tofu (bean curd). An increased GFR was only observed after tuna fish. This was accompanied by an increase in glucagon and growth hormone as well as three AAs (alanine, glycine and arginine)Simon 1998^36^8 healthy volunteersXXA chicken or equivalent beef meal induces identical GFR and RPF response. RVR decreases as GFR and RPF increase. FF remains unchangedOrita 2004^37^6 healthy male subjectsXXOffering a beefsteak or the same amount of skim soy with soy sauce results in an identical enhancement of GFR. AA analysis revealed no differences between the two protein challengesLow sodium diet (20 mmol/d and furosemide 80 mg once)Ruilope 1986^38^11XXNo increment of GFR when salt-depleted. Recovery when captopril is given. No recovery under indomethacineLow sodium diet (0.5 g) and furosemide 25 mg for at least 3 daysMemoli 1991^39^8 paired observationsXXXIn control conditions, both GFR and RPF increase (+31.5% and +41%) after dopamine and AA stimulation. After salt depletion, GFR and RPF are impaired mainly by an increased vascular resistance. After dopamine and AA, both GFR and RPF increase (+37% and +31%)Low hydration/high hydrationHadj-Aissa 1992^40^10 paired observations. High hydration: 1st h 10 mL/kg, 2nd h 7.5 mL/kg and 5 mL/kg/30 minXXHigh hydration resulting in a low urinary osmolality blunts a protein-induced response of GFRClaris-Appiani 1999^41^7 adults tested 6 timesXXThe renal haemodynamic response is blunted when hypotonic saline is infused (0.23--0.45%)Anastasio 2001^42^12 paired observations. High hydration means 5 mL/kg/30 min. Low hydration means 0.5 mL/kg/30 minXXHigh hydration lowers GFR and preserves response versus low hydration (with a higher unstimulated GFR and lower response)MedicationKrishna 1988^43^9: tested 3 times (placebo, indomethacine, enalaprilXXGFR increased from 101 ± 7 to 118 ± 4 mL/min. Smaller increase after indomethacine. No effect of enalaprilHerrera 1988^44^10 healthy subjects, twice stimulated without and with indometacineXXA protein load induces an increase in GFR from 107.2 ± 6.05 to 146.4 ± 6.79 mL/min/1.73 m^2^ and an increase in RBF. No effect of indomethacineVanrenterghem 1988^45^6 subjectsXXIndomethacine blunts the GFR increaseChagnac 1989^46^12 healthy subjects before and after enalaprilXXCrC increases from 114.3 ± 4.5 to 137.1 mL/'/1.73 m^2^ after a protein load. On the enalapril intake day, the increase of CrC was lowerMizuiri 1994^47^6 controls10 controls and 10 IgAN patients before and after captoprilX (L-Arg)XL-arginine infusion leads to a significant decrease in RVR and a significant increase in RPF and GFR in all groups. An increase in plasma glucagon levels was observed. Captopril pretreatment in healthy subjects attenuates this effectPritchard 1997^48^23 patients with hypertension (four-way crossover)XXXTandolapril 2 mg and indomethacine 3 times 25 mg: no effect on GFR or ERPF after dopamine and AABody compositionDeibert 2011^49^10 male patients with the metabolic syndrome10 controlsXXThe obese subjects show a higher baseline GFR and RPF. The protein load induced a significant increase in GFR and RPF in healthy controls and even more in patients with metabolic syndromeAnastasio 2017^50^28 obese20 controlsXXDelayed glomerular response in obese patientsTime of dayBuzio 1988^51^7XXBest CrC stimulatory effect when protein load is administered at lunch (instead of supper)Buzio 1989^52^10XXCircadian rhythm. No effect of placebo when given in the evening[^3]Table 5.Current experience with renal stimulation testing in subjects with kidney disease (for reference list, see [Supplementary material](#sup1){ref-type="supplementary-material"})Clinical contextConditionRefNumberType of stimulusType of GFR measurementResultDopamineAAProtein mealCreatinine IVUrinary Inulin (+ PAH) clearanceUrinary CrCExogenous markerHyperechogenicityPotential kidney donorsFouda 2011^53^34 potential kidney donors with Grade 1 hyperechogenicity, 10 matched healthy donorsXXMAG 3The renal reserve is comparable in the two groups. In 41% of 17 biopsies of the donors with abnormal ultrasound, morphologic abnormalities are present, compared with only 1 of 8 biopsied controlsSingle kidneyPost-donationBosch 1984^3^5XXCrC increases from 70 ± 14 to 83 ± 4 mL/minIturbe 1985^4^25XXCrC increases from 115.4 ± 11.6 to 137.4 ± 11.6 mL/minter Wee 1986^5^9XXIOTH 1GFR shows only increment on double stimulationSolling 1986^9^8 meat meal7 amino acidXXXShort-term protein load and AA, increased RPF and GFR and decreased RVR. The permselectivity of the GBM was unchangedter Wee 1987^54^18 after uninephrectomy,10 kidney donors (pre and post)XIOTH 1GFR increases 4.5% versus 10% in controls. After donation in paired observations, the GFR increase decreases from 12.4% before to 5.9% after nephrectomyCassidy 1988^55^12XXLower CrC in donor group but comparable increase on placebo.Amore 1988^56^6 patients after unilateral nephrectomy8 healthy subjectsXXPatients with single kidneys show albuminuria at baseline, while their CrC is normal. After a protein load, albuminuria increases while their CrC response is lower than in controlster Wee 1990^57^20 pre and post observationsXXIOTH 1After donation: 65% of pre-donation GFR, lower FF. Dopamine: increase of GFR, with 13.8% before versus 5.3% after donation. AA-induced increase: 11.2% before versus 9.6% after. Combined: 20% increase before versus 12.6% after donation. ERPF helps maintain GFRHeering 1994^58^8 controls 8 renal graft recipients 8 after nephrectomyXXA RFR is shown in healthy controls but a grossly diminished response is seen in patients with a single kidneyter Wee 1994^59^15 pairs (donor/recipient)12 long-term follow-upXXIOTH 1Preserved increase in GFR on AA stimulus, less after dopamine. Long-term RFR is preserved, less due to increased ERPF than to glomerular hypertrophyRodriguez-Iturbe 2001^60^14 normal controls7 donors11 after kidney transplantationXXIOTH 2An IV bolus of creatinine stimulated tubular secretion in controls (11.3 times), in donors (4.3 times) and in transplanted patients (2.5 times)Rook 2006^61^125 kidney donors 120 days before and 57 days after donationXXIOTH 1GFR post-donation was predicted by GFR~pre~, GFR~max~ and ageRook 2008^62^178 kidney donors, 4 months before and 2 months after donationXIOTH 1Dopamine-induced increase in GFR was reduced from 11 to 5% after nephrectomy. Dopamine-induced increase correlated negatively with donor age and BMISpinelli 2017^63^7 pairs donor/recipientXXSum of stimulated CrC of donor and recipient equals pre-donation stimulated CrCVan London 2018^64^105 female kidney donors ages \<45 years51 donors with a BMI \>25 kg/m^2^XIOTH 1Donors were tested 4 months before and 2 months after donation. Female donors with a BMI \>25 kg/m^2^ showed an absent functional response. BMI correlated with RFRAfter resection of Wilms tumourBhisitkul 1991^65^12XXNo differences in CrC before and after oral protein load in single kidneys versus controlsRegazzoni 1998^66^37 after nephrectomy in childhoodXXLong-term follow-up shows stable GFR but decreasing increase of GFR after oral protein loadDonckerwolcke 2001^67^11 patients after nephrectomyXXGFR and ERPF are well preserved. At rest, tubular secretion of creatinine is stimulated. Two patients show maladaptation with loss of RFRRenal agenesisDe Santo 1997^68^21 adults with unilateral renal agenesis (3 groups with declining GFR)XXXHigher blood pressure and proteinuria in patients with lowest GFR. Normal response after protein load in all groups. CrC overestimated GFR by 32.7%Renal transplantationCairns 1988^69^9 renal transplants on cyclosporine9 azathioprine-treated renal transplantsXXEDTA 1After a protein load, azathioprine-treated renal transplantation showed a significant increase of GFR and ERPF compared with cyclosporine treated renal transplantsNunley 1991^70^6 RT on cyclosporine7 RT on azathioprineXXCyclosporine alters the renal response to a protein mealRondeau 1993^71^18XXRFR: increase from 50 to 60 mL/min. No effect of ACE inhibitors. Less RFR if cyclosporine treatmentAder 1994^72^12 patients studied at20 days and 7.6 months8 single kidneys12 controlsXXRenal transplant patients show a GFR increase after AA stimulusShokeir 1994^73^152 donor/recipient pairs: 40 paediatric recipients, 112 adult recipientsXXDTPA 2The GFR of paediatric recipients is significantly lower. The functional response of the transplanted kidney was assessed after 4--8 months. Also, graft functional reserve proved lower in paediatric recipientsChagnac 1995^74^6 on cyclosporine before and after 2 weeks with high-dose nifedipineXXHigh-dose nifedipine increases renal perfusion, decreases FF and RVR but RFR remains absentHansen 1995^75^9 healthy volunteers9 on cyclosporine9 without cyclosporineXDTPA 1A 10-week dietary supplementation with fish oil did not induce significant renal function improvement. On low-dose cyclosporine, a well-preserved renal response is demonstratedPluvio 1996^76^16 transplanted patients on cyclosporine6 nephrectomy patients7 on cyclosporine9 controlsXXNo renal functional response on cyclosporine treatment, both transplanted and non-renal patients. Basal GFR correlates with renal allograft volume (measured by ultrasound)Hansen 1996^77^8 on cyclosporine8 on azathioprineXXDTPA 1Low-dose cyclosporine A does not attenuate the renal response after dopamine or AA infusionEnglund 1996^78^36 renal transplanted children, 15 donors and 15 single kidneysXXBaseline GFR and ERPF is lower in transplanted patients. Increases are similar. Stimulated GFR and ERPF correlated with kidney lengthMaranes 1998^79^11 patients with 'en bloc' transplantation10 controls (single kidney transplants)XXPatients having received an 'en bloc' pediatric kidney transplantation show a greater renal response (and a lesser risk of hyperfiltration)Fagugli 1998 ^80^25 kidney transplanted patients8 controlsXXA group of renal transplants shows no RFR but rather a reduction of GFR, a higher FF and a high level of thromboxaneZhang 1999^81^5 normal volunteers21 renal transplants on cyclosporine (10 with normal renal function)X (L-Arg)XL-Arg increased GFR from 103 ± 9 to 122 ± 7 mL/min/1.73 m^2^ in control subjects. In transplanted patients, no increase of GFR was observedEnglund 2000^82^30 children7 recipient/donor pairsXXStable GFR and preserved increase on repeated measurements. Donors tend to show a higher response. Max GFR is related to kidney volumeBertoni 2001^83^40 grafted with a kidney younger than 55 years40 grafted with a kidney older than 55 yearsXCrC increases at 6 months and after 1 year. The increase in the CrC is higher in kidneys from younger donors. This increase is inversely related to donor baseline GFRDelclaux 2001^84^11 out of 14 patients, \>20 years after transplantationXXEDTA 17 of 11 patients show an RFR that is lower than median. No correlation was found with morphological data (unless a slightly higher glomerulosclerosis rate in this population). In 4 of 11 patients a functional response is present, even \>20 years after renal transplantationFulladosa 2003^85^32 transplanted patients on cyclosporineXXXCorrelation of renal response with renal biopsy. The presence of arterial hyalinosis is the only histological parameter associated with impaired renal responseKamar 2006^86^10 patients on FK and sirolimus7 patients on FK and MMFXXSimilar GFR and renal functional response after 6 and 12 months post-transplantation. No correlation with histology.Saurina 2006^87^14 patients before and 8 months after conversion to sirolimusXDTPA 1More proteinuria and higher calculated glomerular filtration pressure after conversion of CNI to sirolimusHeart transplantationAder 1996^88^12 renal and 13 heart transplants8 single K and 12 controlsXXMaximal increase of GFR after heart transplantation (7 months) is lower than in controls. No increase in ERPF was seen in heart transplanted patientsHeart FailureMagri 1998^89^10 (mild HF, compensated)XXNo vasodilatory response on AA in mild HF. Restored response after treatment with RAS blockerFrangiosa 1999^90^9 patients with end-stage HF (ACE inhibitors, diuretics)18 controlsXXGFR and ERPF are higher in normal controls, but the percentage increase after a protein load is conserved (27%) in HF patients, although they show a high FF (35%)Coronary artery diseaseFuiano 2005^91^15 patients with an indication for coronary angiography15 kidney donors as a control groupXXUnstimulated: lower ERPF in CAD, higher FF. Lower RPF dependent on severity of CADAfter AA infusion: no increase of GFR in CAD.After 2 years: decrease in GFR and RPF. Unchanged response to AA.Cardiac surgeryMazzarella 1991^92^11 adult patients scheduled for coronary artery bypass graftXXPatients were tested before, as well as 9 days and 6 months after cardiac surgery. At 9 days, no significant renal response could be shown. The renal response was restored at 6 monthsPregnancyRonco 1988^93^29 pregnant subjects were tested at different stagesXXXResting CrC increases during pregnancy. Increment in CrC decreases during pregnancy. Peak GFR is 160 mL/minLate gestation compared with 3 months post-partumBarron 1995^94^14: protein challenge8: carbohydrate challengeXXGFR is higher during gestation and even higher than post-protein load in post-partum women. Placebo during pregnancy is less effectiveEarly and late gestation compared with 3 months post-partumSturgiss 1996^95^14: AA infusion7: crystalloidXXGFR increases in early and late pregnancy. Percentage increase is not different from post-partum. Unstimulated GFR is 40% higher during pregnancyHeguilén 2001^96^8 pregnant women (15 weeks)5 controlsXXPregnant women still show an increased CrC on protein loadingMid-termHeguilén 2007^97^8 hypertensive pregnant, 5 non-hypertensive, 8 controlsXXAfter protein challenge, hypertensive pregnant women show a lesser increase of CrC than normal pregnant womenCohen 2012^98^Healthy pregnancy = 15Pregnancy and CKD = 25Non-pregnant women = 8XXIn controls, baseline CrC increases from 99.8 ± 2.9 to 149 ± 4 mL/min. In healthy pregnancy, baseline CrC increases from 118.5 ± 3.2 to 223.4 ± 5.2 mL/min, a 90% increase. In CKD pregnancy, baseline CrC increases from 132 ± 7.6 to 186 ± 10.3 mL/min, a 40% increaseLiver cirrhosisHirschberg 1984^99^8XXNo increase of the GFR after a protein loadRodriquez 1999^100^10 patients with Child A liver cirrhosis10 controlsXXGFR and ERPF are lower in patients with cirrhosis. The functional reserve is similar. Higher levels in cGMP and NO were seen in patients, probably to compensate for angiotensine II effectsWoitas 2002^101^22 patients with decompensated liver cirrhosis and ascitesXXBaseline GFR and ERPF were low. After AA infusion the GFR increases by 67% and ERPF by 29%Woitas 1997^102^12 patients with liver cirrhosis and portal hypertensionXXBaseline GFR and ERPF were lower. In both groups GFR and ERPF are increased after AA infusion. The degree of ERPF increase is higher in cirrhotic patientsLiver transplantationBadalamenti 199513 treated with fish oil13 with corn oil, during 2 monthsX (L-arg)XTwo months treatment with fish oil improves renal hemodynamics, no effect on RFR.NephrotoxicityOccupational exposure to leadRoels 1994^103^76 male lead workersXXBoth controls and lead workers showed a significant increase in CrC of 15%. Baseline and stimulated CrC is higher in lead workersGenetic risk of essential hypertensionO'Connor 2001^104^26 normotensives with positive familial risk of hypertension13 controlsXXXRFR is already blunted in still normotensive subjects at genetic risk of hypertension. Potential explanations: insulin resistance to the amino acid--translocating effects of this hormone, baseline hyperfiltration and decreased proximal tubular reabsorption during amino acid infusionHypertensionLosito 1988^105^34 mild to moderate HT (22 controls)XXLess increase in CrC after AA infusion. Some patients show no RFR: CrC correlates with albuminuria in these patientsValvo 1990^106^15 hypertensives12 healthy subjectsXIOTH 2RFR is identical to controls. ACE inhibitor does not influence the amount of RFRBuzio 1994^107^16 hypertensives with apparently normal GFR with and without nifedipine and captoprilXIOTH 1Nifedipine increases GFR, ERPF as well as urinary excretion of proteins after a protein load, while captopril decreases GFR and proteinuriaCottone 1994^108^16 newly diagnosed patients with essential hypertension10 healthy controlsXXAmong 16 patients, 13 showed an increased CrC after AA infusion. No correlation was found with plasma renin activity, aldosterone concentration, circulating norepinephrine and endothelin-1Tietze 1997^109^12 controls14 patients with essential hypertensionXXGFR increases in healthy controls with and without ramipril. In hypertensive patients, ramipril inhibits the increase in RPF. Long-term treatment with ACE inhibitor blunts the response of GFR and RPFBelsha 1998^110^33 normotensive adolescents29 hypertensive adolescentsXXNormal functional response in hypertensive adolescents. No renal pathology even with left ventricular hypertrophyZitta 2000^111^15 controls, 16 hypertensive patientsXXNo increase of GFR in hypertensive patients unless partial recovery after carvedilol and not after fosinopril treatmentObesity + hypertensionPecly 2006^112^14 obese and AHT9 lean and AHTXXIn obese patients, GFR and RPF are higher. Response after protein load is lowerTeunissen-Beekman 2016^113^Out of 79 overweight individuals with untreated hypertension and normal GFR, 27 on maltodextrin and 25 on protein mix participatedXXGreater decrease in FF after a protein supplemented breakfast following a 4-week course of protein supplementationGaipov 2016^114^10 hypertensive nephropathy14 hypertensive without nephropathy11 controlsXXLower RFR in hypertensive patients. Correlation with renal resistive index and proteinuriaADPKDHarrap 1992^115^19 ADPKD20 controlesXXLower ERPF in ADPKD patients, also stimulated renin--angiotensin system and higher body sodium load. Non-significant increase in GFR after oral protein loadSclerodermaLivi 2002^116^21 scleroderma patients with normal creatinine10 controlsXXUnstimulated: lower CrCStimulated: less increase of CrC. The response is dependent on MAP and unstimulated CrCLivi 2011^117^28 normotensive scleroderma patientsXX19 patients had an RFR defect and 9 showed a normal RFR. Those patients had a lower BP. After 5 years: 13 of 19 showed a reduction of CrC \>2mL/min/yearAmin 2012^118^30 patients with scleroderma30 controlsXDTPA 2High prevalence of lower RFR in scleroderma patients. Pulmonary hypertension correlated with abnormal RFRSLENo CKDKhusnutdinova 2014^119^30 versus 40 controlsXXRFR was 41% in controls and lower in SLEPoststreptococcal GNNo CKD on follow-upIturbe 1985^4^35 patientsXXCrC rose from 82.0 ± 6.45 to 90.3 ± 5.3 mL/minChronic glomerulonephritisNo CKDTietze 1994^120^13 biopsied CGN13 controlsXIOTH 1Renal response and glomerulo-tubular balance are intact. Abnormal lack of suppression of the renin--angiontensin--aldosterone system after AA infusionIgA nephropathyBach 1994^121^7 with modest impairment2 nephrotic9 controlsXXGFR and ERPF increased in controls and patients without nephrotic syndrome. No increase in the two nephrotic patientsBeukhof 1985^122^32XIOTH 1Dopamine induces GFR-only effect when baseline GFR \> 73 mL/min/1.73 m^2^GFR 64 mL/min,Diet: 0.9--1.3 g/kg/d proteinPluvio 1996^123^7 stage II, 8 stage III-IV and 12 controlsXXRFR 20% in Stage II comparable to normals. No RFR in Stages III--IVDe Santo 1997^124^10 proteinuric IgAN patients20 controlsXXXGFR was lower and FF was higher at baseline in patients. GFR increase following protein load was comparableSulikowska 2004^125^20 patients before and 1 year after treatment with Omega-3XXOmega-3 polyunsaturated acids improve dopamine-induced GFR response and lower proteinuria and NAG excretionSulikowska 2008^126^5015 controlsXXLess response on dopamine, higher NAG and FeUASulikowska 2012^127^46 patients15 controlsXXLower DIR in patients. Correlation of EPO with uric acid clearance: more EPO and reduced urate clearanceSulikowska 2015^128^46 non-nephrotic IgAN patients15 controlsXXIgAN patients were separated in subjects showing a decrease in EPO levels versus those showing an increase in EPO levels. A decreasing EPO level was associated with a preserved CrC response, less proteinuria, less NAG and lower uric acid and blood pressure while kidney biopsy findings were comparableHIV nephropathyMarques 1998^129^6 healthy9 asymptomatic carriers of HIVXXCrC increases in healthy subjects. In HIV carriers a lower response is observedSickle Cell anaemiaHerrera 2002^130^16 sickle cell A20 controlsXXIOTH 2SCA patients have a higher GFR at baseline, but no increase in tubular secretion of creatinineCKDAltered renal functionBosch 1983^1^6XXSome have RFR while others notCKD1a, CKD1b, CKD2, CKD4Bosch 1984^3^CKD1a (4), CKD1b (13), CKD2 (9), CKD4 (5)XXXCKD1a: from 149 ± 12 to 165 ± 13 mL/minCKD1b: from 109 ± 8 to 124 ± 16 mL/minCKD2: from 70 ± 14 to 86 ± 12 ml/minCKD4: from 22 ± 6 to 24 ± 6 ml/minCKD 1, CKD 2-3, CKD 4ter Wee 1985^131^CKD 1: 9CKD 2--3: 11CKD 4: 7XXIOTH 1Variable GFRBosch 1986^8^10XXGFR increases from 63 ± 29 to 76 ± 37 mL/min dependent on severityColome 1987^132^16 controls (13 adults and 3 children)31 patients (22 adults and 9 children)XXNo response if clearance is \<40 mL/min and in patients with acquired or congenital solitary kidney. The presence of proteinuria is not associatedCGNChan 1988^133^12 patients12 controlsXXNo acute effect on glomerular barrier size selectivityReduced number of functioning glomeruliZuccala 1989^134^20 with 15--70% sclerotic glomeruli10 with acquired single kidney5 with surgical ablation of \>50% of renal mass24 controlsXXRFR is not necessarily reduced or absent in patients with a reduced number of functioning glomeruliCKDKrishna 1991^135^15 CKDXXPreserved renal reserve in CKD patients not influenced by enalaprilUemasu 1991^136^8 healthy subjects9 subjects with CGN and baseline GFR \>90 mL/min8 subjects with baseline GFR between 40 and 90 mL/minglucagonTHIONormal controls show an increase in GFR and ERPF. CGN with preserved GFR showed no increase in ERPF, while patients with lower GFR showed no effect on GFR while ERPF increasesLoo 1994^137^32 with CKD19 post-transplantation12 kidney donors62 healthy controlsXXRenal response in healthy subjects was 31 mL/min. Lower response in CKD patients: 13.5 mL/min. Same response in transplant recipients. Lower response in donors: 5.4 mL/minDe Santo 1997^138^10 healthy subjects10 CKD patients (GFR = 40 mL/min)XXSimilar increase of GFR in healthy and CKD patients. Renal tubules contribute to the acid/base balance in both groups by reabsorbing most of the bicarbonate loadCKD on low protein dietCianciaruso 1994^139^14XXXLower effect of stimulus in patients even after low-protein diet, while in controls an increased effect is seen on a low-protein dietCKD 1-2CKD 3CKD 4De Santo 1995^140^CKD 1--2 = 115CKD 3 = 85CKD 4 = 73XXCompared with 85 healthy subjects, renal disease patients peak later after a protein meal. Cumulative GFR increase is less in renal diseaseHerrera 1998^141^12 controls7 donors8 CKDXXXComparison of inuline and CrC reveals that there is a limited tubular secretion of creatinine dependent on renal massDe Nicola 1999^142^21 proteinuric CKD patients: 11 for 6 months on L-arginine and 10 controlsXXNo improvement of 6 months treatment with arginine supplementation on renal functional responseBarai 2010^143^25 controls100 CKDXDTPA 1Control mean renal reserve = 23.4%CKD 1 = 19.08%CDK 2 = 15.4%CKD 3 = 8.9%CKD 4 = 6.7%DiabetesBosch 1986^8^18XXGFR decreases from 118 ± 46 to 102 ± 37 mL/minInsulin-dependent (type 1)ter Wee 1987^144^14XXIOTH 1130 mL/min baseline GFR, lesser increase after AA than controls dependent on baseline GFR (negative correlation)Type 2 DMNakamura 1989^34^A: no albuminuriaB: microC: macroXXNo albuminuria: normal GFR increase. Microalbuminuria: no GFR increase. Macro: GFR decreases after placeboType 1 DMNosadini 198915 IDDM (\>9 years), 8 with and 7 without albuminuria8 controlsXEDTA 1Comparison of AA and ketone body infusion shows that renal response in long-standing DM type 1 patients is not presentType 2 DM with nephropathyBrouhard 1990^145^8 patients on low- protein (0.6 g/kg/d) and 7 on normal dietXXRFR measured at 6-month intervals during 1 year decreased as well as resting GFR in patients on normal dietType 1 DMDedov 1991^146^10 patients with type 1 DM without diabetic nephropathy7 healthy controlsXXPatients with normal RFR show a lower baseline GFR. Patients with no RFR have a higher resting GFR and demonstrate hilar glomerular lesions with severely expanded mesangium, apparently preceding overt nephropathyType 2 DMTuttle 1992^147^12 diabetic patients without insulin treatment9 normal subjectsXXDiabetics show a higher baseline GFR and ERPF, as well as a more prominent RFR. This does not change after 36 h of insulin infusion. A 3-week course of insulin therapy diminishes the exaggerated renal response and the volume of the right kidney without normalizing itSackmann 1998^148^33 patients: 14 early stage, 10 microalbuminuric, 9 late stage12 controlsXXEarly stage (at high GFR) and late stage (proteinuric and lower GFR) show less responseType 1 DMSackmann 2000^149^10 with nephropathy, 10 without15 controlsXXLess increase of GFR in patients with nephropathy (proteinuria and hypertension) even when GFR is preservedType 2 DMGuizar 2001^150^181 recently diagnosed type 2 -\> 28 studied, 7 controlsXX75% of patients show microalbuminuria. Studied microalbuminuric patients lose response on protein loadType 2 DMEarle 2001^151^9 African-Asian diabetes9 white patientsXXLess response in patients of African-Asian descent due to defective NO production or bioavailabilityType 1 DMAssan 2002^152^285 IDDM treated with cyclosporine100 IDDM not treated with cyclosporineXX10--12% functional response, conserved even after 7 and 10 years of low-dose cyclosporine treatmentType 1 DMTuttle 2002^153^12 DM type 112 controlsXXDiabetics have a higher GFR and FF. AA and glucagon induce GFR to rise via a different pathway. Glucagon can be inhibited by indomethacineType 1 DMZaletel 2004^154^22 patients without renal diseaseXXRenal response is inversely related to CRP, linking endothelial dysfunction with renal haemodynamic behaviourType 1 DMSulikowska 2007^155^30 sulodexide and 13 notXXSulodexide helps in improving dopamine-induced GFR response and lowering of NAGMueller 2009^156^28 diabetic patientsXXPreserved RFR in 6 of 28 patients. No correlation with cystatin CChildren (\< 18 years)Hellerstein 2004^157^89 studies in 78 childrenXX + cimetidineFollow-up of CACrC after a meat-free protein meal is non-invasive and inexpensiveSolitary kidneysPeco-Antic 2012^158^22 patients30 controlsXX + cimetidineCACrC and cystatin C were compared. Half of the patients had decreased RFR. Cystatin C was a strong predictor. Also, blood pressure was a determinantCKDMolina 1988^159^Normal: 386CKD: 21XXXA normogram was constructed with p10 and p90. Negative correlation of stimulated GFR with unstimulatedDe Santo 1990^160^Normal: 1110 children with mean creatinine 2.6 mg/dLXXEarlier peak GFR in healthy children. Greater increase of GFR and RPF in diseased childrenOffspring of hypertensive parentsGrunfeld 1990^161^21XXLack of GFR increment in offspring of hypertensive parents is associated with higher albuminuriaType 1 DMSemiz 1998^162^22 patients (11 with \>5 years of diabetes, 11 with shorter duration)15 healthy controlsXXRenal functional response is lower after a longer duration of diabetes. This pathology is present without albuminuriaRaes 2007^163^51 diabetic children34 controlsXXUnstimulated GFR is similar, increased FF. Lower RFR in patientsPrevious post-streptococcal GNCleper 1997^164^36 patients (5--21 years old) without renal function anomalies12 controls (2--12 years old)XXSimilar basal CrC. The functional response is lower in patients after a post-streptococcal GNPrevious HUSPerelstein 1990^165^17: previous HUS11: single kidney15: controlsXXChildren with a history of HUS show an abnormal RFRTufro 1991^166^16XXProtein content in the diet influences CrCDieguez 2004^167^26: tested two times15 controlsXX + cimetidineCACrC rises after a protein load in both patients and controls. When distinction is made between responders (\> 36% increase) and not, non-responders develop proteinuria. They had a longer oliguria period during their HUSBruno 2012^168^33 children with previous HUS (18 males, 15 females) with normal CrCXEDTA 2Half of the children showed a GFR increase of at least 20%, judged as a normal responseReflux nephropathyCoppo 1993^169^28 children with surgically corrected bilateral vesico-ureteric refluxXChildren with severe renal parenchymal scarring had greater albuminuria and beta-2 microglobuline in basal conditions. Both increased after AA infusions. CrC increases alsoMatsuoka 2009^170^35 patients with reflux nephropathy, glomerular size evaluated on renal biopsyXTHIOWhen glomerular size was normal, DIR was good and ERPF was unchangedWhen GS was enlarged, GFR and ERPF increased bothWhen GS was extremely enlarged, both GFR and ERPF remained unchangedUnilateral ureteropelvic junction obstructionMontini 2000^171^4 boys and 1 girl after pyeloplasty with contralateral kidney as controlXXGFR at baseline was greater in normal than in surgically treated kidney. Aspirin decreases GFR in operated kidneys. Lower GFR increase after protein loads in operated kidneysPosterior urethral valveAnsari 2011^172^25 patients, at least 6 weeks after fulguration of posterior urethral valveXDTPA 1In more than a third of patients, RFR is depleted. They had more bladder dysfunction and more severe vesicoureteral reflux[^4]

In the meantime, progress is being made in the development and validation of fluorescent markers for GFR determination. These intravenously injected compounds behave as an ideal renal filtration marker. Their plasma disappearance curves match glomerular filtration and can be read transdermally thanks to their fluorescent properties. In this way, an almost real-time GFR evaluation is possible \[[@sfy022-B72], [@sfy022-B73]\].

[Table 3](#sfy022-T3){ref-type="table"} describes in more detail the advantages and disadvantages of the numerous options. Tabe 3**Advantages and disadvantages of the different options mentioned in [Table 1](#sfy022-T1){ref-type="table"}**OptionProsConsEvaluationDiet 1: habitual dietEasiest protocol. Protein intake can be evaluated by the urinary nitrogen appearanceUnstimulated GFR is influenced by the protein content of the habitual diet. The renal response may be lowerSimplicity: highDuration: lowCosts: lowValidity: lowerDiet 2: 10 days of low-protein or vegetarian dietBest guarantee of approaching unstimulated or resting GFRRequires the effort of a dietician and the subject's complianceSimplicity: lowDuration: longCosts: higherValidity: higherStimulus option 1: oral protein load in the form of cooked meatEasiest to prepare. Oldest and most extensively documented challengeSubjects must ingest the meal in 30 min. In case of gastric emptying disorders, digestion can be slowerSimplicity: highDuration: lowCosts: lowValidity: neutralStimulus option 2: oral protein load without creatinineThe taste can be adapted to subjective wishes. Can be used in childrenRequires the effort of a dietician to compose the meal. The tubular secretion of creatinine is missedSimplicity: neutralDuration: lowCosts: lowValidity: neutralStimulus option 3: IV dopamineLow-dose dopamine augments the renal plasma flow more than the GFROnly offering a haemodynamic stimulus.Mostly used in combination with an AA infusion. Requires an extra IV line and clinical follow-up. Dopamine has fallen into disuseSimplicity: lowDuration: lowCosts: highValidity: lowerStimulus option 4: IV AA infusionIf AA plasma levels are more than tripled, this stimulus offers the best guarantee of maximal GFR simulationAA composition must match those used in literature. Infusing AA may cause phlebitisSimplicity: lowDuration: highCosts: highValidity: highestStimulus option 5: IV glucagonShortest stimulus. Physiologically logical stimulusRequires glycaemic controls. Misses simultaneous insulin secretion as in normal physiology. Less experience and literature supportSimplicity: lowDuration: lowCosts: highValidity: lowerGFR option 1: exogenous markerBest GFR measurement. Current literature proposes a bolus/continuous infusion protocol for the evaluation of unstable renal functionIn case of a single bolus injection: unstimulated and stimulated GFR measurements must be scheduled on two separate days.Simplicity: lowDuration: neutralCosts: highValidity: highestGFR option 2: creatinine clearanceEasiest protocol. Evaluates glomerular filtration as well as tubular secretionCrC overestimates true GFRSimplicity: highDuration: neutralCosts: lowValidity: neutralGFR option 2:CACrCIf tubular inhibition is maximal, CACrC matches measured GFRMaximal tubular inhibition of creatinine secretion cannot be guaranteed. Potential side effects of cimetidine (allergy and tolerance). The tubular contribution to overall clearance is blockedSimplicity: lowerDuration: higherCosts: higherValidity: high[^5]

Alternatives to GFR measurements
--------------------------------

Magnetic resonance imaging (MRI) holds great promise, as it allows for simultaneous measurements of both the GFR and renal plasma flow (RPF) \[[@sfy022-B74]\], as well as providing estimates of single-nephron GFR. Additionally, MRI could be used to quantify renal fibrosis, as recent evidence suggests \[[@sfy022-B75]\].

Doppler ultrasound can detect the decrease in RVR occurring in healthy kidneys after a protein challenge \[[@sfy022-B76], [@sfy022-B77]\]. This has led investigators to study the renal resistive index variation (RRIV) before and after an AA infusion. A similar decrease in RVR can be documented when pressure is applied to the retroperitoneal vasculature. This autoregulatory reflex is intended to preserve the GFR. Maximal renal vasodilation was recorded when a saline bag representing 10% of the body weight was placed on the abdomen. The maximal RRIV observed in these experiments correlated with the RFR, thus offering a non-invasive real-time evaluation of the changing RVR \[[@sfy022-B78]\].

CLINICAL SUPPORT OF RENAL STIMULATION TESTING
=============================================

Over the last three decades, numerous publications have reported on the renal stimulation test in various healthy and diseased populations (summarized in [Tables 4](#sfy022-T4){ref-type="table"} and [5](#sfy022-T5){ref-type="table"}). An exhaustive literature search of RFR testing proves very challenging because of the heterogeneous nomenclature, necessitating several surveys and meticulous scrutiny of the references. Surprisingly, only a minor fraction of studies investigated \>50 subjects. Molina *et al.* \[[@sfy022-B79]\] decided on a sample size of 384 children, considering a standard deviation of the GFR of ±20 mL/min to find a pre--post difference of at least 2 mL/min. Despite this fundamental statistical consideration, most papers omit biological variance and inter-person variability in their discussions.

The first studies were performed in healthy individuals ([Table 4](#sfy022-T4){ref-type="table"}). Several different stimuli were used. It was shown that inulin clearances could rise to 130--150 mL/min while CrCs reached 160--180 mL/min \[[@sfy022-B7]\]. These studies also demonstrated that the protein content of the habitual diet influences unstimulated GFR and determines the absolute extent of the GFR increase after a protein load \[[@sfy022-B80]\]. Hypovolaemia is an appreciated cause of a blunted response \[[@sfy022-B38]\]. Healthy elderly individuals show a lower GFR and less effect after stimulation, most probably because they rely on fewer nephrons \[[@sfy022-B83]\]. Recently Denic *et al.* \[[@sfy022-B86]\] demonstrated that the single-nephron GFR (in unstimulated circumstances) remained remarkably stable in a large cohort of living kidney donors until the age of 70 years. The age-dependent decline of the GFR in elderly donors was attributed to a lower nephron count and a lower metabolic need without the presence of kidney disease.

Overweight people show an increased unstimulated GFR and less exploitable filtration capacity \[[@sfy022-B87]\].

Kidney donors as well as patients with a congenital single kidney were extensively studied ([Table 5](#sfy022-T5){ref-type="table"}). The expected response after a fixed protein meal or an AA infusion is generally preserved in single kidneys, even several years after nephrectomy. Dopamine accomplishes less stimulatory effect, as ERPF is already maximally increased \[[@sfy022-B45]\]. Long-term follow-up reveals that the gradual increase in the GFR in the post-transplant period is achieved by glomerular hypertrophy instead of an increased ERPF \[[@sfy022-B88]\]. Regazzoni *et al.* \[[@sfy022-B89]\] described an unchanged GFR several years after a nephrectomy in childhood. However, an oral protein load proved gradually less effective in evoking an adequate response. Transplanted kidneys show less response to a protein stimulus when treated with cyclosporine compared with patients treated with a calcineurin-free regimen, mostly azathioprine \[[@sfy022-B90]\]. The extent of the GFR increment after a stimulus correlated with kidney size (i.e. length or volume). Kidneys from younger donors exhibited a better renal response after a stimulus and this was dependent upon the unstimulated GFR of the donor \[[@sfy022-B91]\]. The native kidneys of patients after a heart transplantation tended to show less response than the single transplanted kidney \[[@sfy022-B92]\]. This was attributed to pre-existent cardiovascular damage, absence of renal denervation or a slightly higher cyclosporine trough level.

Hypertensive patients challenged with a protein meal, demonstrate a weaker or absent renal response. The presence of albuminuria indicates subclinical damage with abolished filtration reserve. A significant negative correlation was shown between the renal response and the renal resistive indices, evaluated by ultrasound \[[@sfy022-B77]\]. In the offspring of hypertensive parents, the RFR proved lower and was associated with albuminuria \[[@sfy022-B93]\]. Fifteen patients planned for a coronary angiography were matched with as many healthy peers. Their ERPF was lower and correlated with the extent of coronary lesions \[[@sfy022-B94]\]. No response on AA infusion could be documented in patients with coronary artery disease.

IgAN cases were studied after AA and dopamine infusions. A diminished renal response was present in patients with more prominent histological lesions (with \>50% of the glomeruli showing proliferation and \>15% of the glomeruli with crescents or segmental lesions) \[[@sfy022-B95]\]. Another study correlated a lower GFR increase to injury biomarkers such as proteinuria and NAG excretion \[[@sfy022-B60]\].

Livi *et al.* \[[@sfy022-B96]\] studied patients suffering from systemic sclerosis and found that they displayed a lower stimulated GFR. Followed for 5 years, scleroderma patients without increasing GFR at the start lost kidney function at a faster rate of \>2 mL/min/year. This study is one of the rare prospective reports. Children tested after a previous episode of haemolytic uremic syndrome showed variable response after a protein meal. Low responders (\<36% increase) developed proteinuria later in life \[[@sfy022-B97]\].

When renal function is decreasing, the amount of exploitable filtration capacity decreases but stays measurable even in patients with Stage 4 CKD \[[@sfy022-B98]\]. This contrasts with the former theory of RFR, claiming that the reserve capacity is fully utilized before the GFR drops below 50 mL/min \[[@sfy022-B80]\].

In a small study, 10 compensated patients with mild heart failure showed no vasodilatory response after AA infusion. The response was restored after initiation of an ACE inhibitors \[[@sfy022-B99]\].

A higher GFR is observed in diabetics with hyperglycaemia. In these circumstances, the renal blood flow and the filtration fraction are increased, resulting in a higher intraglomerular pressure. This leads to transient or permanent albuminuria \[[@sfy022-B27]\]. Diabetic patients with overt proteinuria fail to respond with a GFR increase when challenged with a protein meal \[[@sfy022-B100]\].

In pregnancy, the induced augmented renal clearance (we deliberately avoid using the phrase 'hyperfiltration') is observed because of an increased ERPF thanks to relaxin, a vasodilating hormone produced by a healthy placenta. Pregnancy offers the most extensive increment of GFR \[[@sfy022-B104]\]. The filtration fraction of kidneys in pregnancy is normal or decreased \[[@sfy022-B105]\]. Only normotensive gravida display a functional response \[[@sfy022-B106]\]. Failure to fully dilate the afferent arteriole and augment ERPF may lead to pre-eclampsia or pregnancy-related hypertension \[[@sfy022-B104]\]. Hence the interest in examining the RFR in women with kidney disorders consulting with a pregnancy wish.

CRITICAL APPRAISAL OF RENAL STIMULATION TESTING
===============================================

The idea of a dormant and exhaustible RFR was flawed as soon as it became obvious that single and transplanted kidneys still show a functional improvement after a protein load \[[@sfy022-B10]\]. This observation led to waning interest in renal function testing and resulted in incomplete scientific explorations: not all renal syndromes have been thoroughly tested. Correlations with histological findings are hardly reported. Moreover, there are no reference data in sickness or in health. Furthermore, longitudinal data linking a decreased stimulatory effect to unfavourable outcomes are scarce. Today, the use of RFR measurements has no place in routine clinical care.

A second criticism is the missing of a renal distress signal, making renal and cardiac stress testing hard to compare. An absent functional response and/or the demonstration of a higher filtration fraction could be viewed as a surrogate for renal maladaptation, potentially leading to progressive nephron loss. This parameter can only be documented when renal clearances of a filtration and a perfusion marker (PAH or ^131^I-hippuran or 99^M^Tc-mercaptoacetyltriglycine) are followed simultaneously. Without the emergence of injury biomarkers, a normal renal response after a protein load implies normal protein tolerance.

In contrast to cardiac stress testing providing the clinician with an early diagnosis allowing for targeted treatment, renal function testing offers the clinician a suggestion of subclinical pathology, but without therapeutic consequences.

A concern is the terminology used. The literature is with confounding nomenclature and consensus definitions are missing.

Renewed interest in renal function testing has been stimulated by nephrologists involved in AKI care. A metabolic challenge could be valuable in assessment of the renal recovery. However, the causative link of diminished renal protein tolerance to a higher susceptibility for recurrent AKI remains debatable.

Finally, renal function testing is relatively labour intensive and requires the allocation of resources. Because the test remains in the experimental context, it is not reimbursed. Spinelli *et al.* \[[@sfy022-B40]\] performed a cost calculation of a simple RFR test using cooked beef as a stimulus and four urine CrC measurements added to 8 h of a nurse's workload. The total cost was €91 for a single RFR estimation. Costs were predominantly driven by the nursing workload, so actual costs may vary substantially between different regions of the world.

FUTURE DIRECTIONS OF RESEARCH
=============================

The first step to be taken is deciding on a common vocabulary. We propose to use the terminology of unstimulated GFR (when all confounding variables are controlled for), random GFR and stimulated GFR. We also advocate rephrasing the terminology of RFR, although firmly embedded in the literature, to renal functional response.

Second, two standard protocols of renal function testing can be proposed, varying in complexity from an elaborate research methodology (encompassing exogenous markers) to a simple scheme with calculated renal CrCs by the means of timed urine collections. However, recent evidence points to the important contribution of tubular secretion in the clearance of protein-bound retention products \[[@sfy022-B107]\]. The tubular contribution to overall renal clearance can be evaluated by simultaneously measuring the clearance of creatinine and an exogenous filtration marker, either after a protein meal or a creatinine load. Alternative stimuli should be explored, for instance serelaxin \[[@sfy022-B108]\].

Third, prospective studies in different disease entities are necessary to link an abnormal renal response to major adverse renal endpoints and provide us with reference values. In [Table 6](#sfy022-T6){ref-type="table"} we present four clinical situations in which the absent response after stimulation might yield meaningful diagnostic and prognostic information: subjects before kidney mass reducing surgery or known to have a diminished number of nephrons, patients in which renal disease is assumed and individuals with an augmented renal clearance. When the eGFR is low, a significant stimulatory response indicates a sufficient nephron quantity. In the case of a diminished or absent increase, CKD can be ascertained. Subjects at high cardiovascular risk may present with a preserved eGFR. If a renal stimulation test fails to induce an increment of glomerular filtration, these patients can be diagnosed as having subclinical kidney disease. A lower as well as a higher GFR have been associated with increased cardiovascular risk \[[@sfy022-B109]\]. No renal response might indicate single-nephron hyperfiltration in both circumstances. Table 6Suggested research topics for renal stimulation testing (adapted and complemented from Molitoris \[[@sfy022-B16]\])Clinical categorySpecific situationDiagnostic information1. Prior to renal mass reducing surgeryBefore kidney donationRisk of CKD post-donationBefore nephrectomy for other reasonsNeed for nephron-sparing surgery or alternative therapies (e.g. radiofrequency ablation)2. In case of congenital or acquired lower renal massCongenital anomalies of the kidney and urinary tractLong-term prognosisAfter kidney transplantationLong-term prognosisAfter kidney donationRisk of progressive renal failure3. In case of suspected renal frailtyBefore major surgeryRisk of AKIBefore pregnancy in high-risk situationsRisk of gestational hypertension and pre-eclampsiaBefore or during chemotherapy or treatment with nephrotoxic drugsEarly nephrotoxicity? Need for dose reduction or change of therapy?In high-risk patients (cardiovascular disease, COPD, OSAS, diabetes, scleroderma, etc.)Early diagnosis of CKDIn geriatric patientsDiscerning renal ageing from genuine CKDIn patients after cystectomy and urinary diversionEarly diagnosis of tubulointerstitial nephritisIn patients with the cardiorenal syndromeDistinction between worsening renal function and true AKIFollow-up after an AKI episodeFully recovered or notFollow-up after inflammatory glomerulonephritisFully recovered or not4. In case of suspected whole kidney hyperfiltrationObesityMaladaptive hyperfiltration or notDiabetes type 1 and type 2Maladaptive hyperfiltration or notSeptic patientsAugmented renal clearance resulting in alternative dosing of antibiotics[^6]

The complexity of the stimulation protocol should match the importance of the anticipated result. Hence the study of kidney donor candidates might receive the greatest attention: maximal stimulus (dopamine in combination with an AA infusion) combined with measured GFR by an exogenous marker. Women at high risk for pre-eclampsia or pregnancy-induced hypertension might be solicited to participate in a simple protein challenge study with urinary CrC. Also, patients applying for bariatric surgery might be tested: an absent functional response could provide the multidisciplinary team with a sense of urgency. Will these patients regain their glomerular reactivity along with the expected reduction of proteinuria \[[@sfy022-B110]\]? Tubular function testing can be interesting in patients with chronic obstructive pulmonary disease or obstructive sleep apnea, with both showing a high prevalence of kidney disease. Can RFR testing before and after starting nocturnal continuous positive airway pressure sort out the questions in this syndrome regarding cause, effect or merely association? Post-AKI patients can be evaluated before they leave the ICU by means of an AA infusion and timed urinary CrCs. In this way, their renal recovery status is better documented and can be correlated with future events. Doig *et al.* \[[@sfy022-B111]\] published a randomized controlled trial in an ICU population of an AA infusion as a preventive strategy for AKI: the primary endpoint was negative but eGFR and urine production increased. Repetitive testing of the glomerular and tubular reserve by a protein load in patients after cystectomy and urinary diversion, might elucidate progressive tubulointerstitial damage even before serum creatinine rises.

Finally, to broaden the scientific foundation of renal function testing, studying the behaviour of renal damage biomarkers during renal stimulation might offer more insight into glomerular and tubular adaptation. Moreover, functional data should be coupled to histological information. Morphological details acquired by MRI or ultrasound can provide additional elements. Obviously these lines of research will greatly amplify the cost of renal function testing and can only be initiated in the context of a study. Eventually comparison of these divergent diagnostic procedures can guide us in choosing the most cost-effective procedure to gain deeper insight into renal health. Several relevant clinical trials ([www.clinicaltrials.gov](http://www.clinicaltrials.gov)) are under way or are awaiting publication. One trial (NCT03190070) includes 30 participants and is testing a liquid protein load in normal and CKD subjects. A second trial (NCT03190070) included 110 patients scheduled for cardiac surgery and performed RFR testing 1 day before and 3 months after the procedure as well as urinary TIMP2-IGFPB7 analysis. Another trial (NCT03190070) plans to monitor 100 patients with a partial laparoscopic nephrectomy and intends to compare the renal protective effect of total versus segmental renal artery clamping by studying the RFR.

CONCLUSIONS
===========

This article offers the most extensive review of renal function testing to date. The authors propose a synthesizing lexicon and advocate a limited number of protocols applicable in future research.

A renal stimulation or stress test aims to document the capacity of an individual to increase his or her kidney function in response to a metabolic need. The stimuli that are proposed are derived from both physiological and experimental evidence. Offering a short-term oral protein load, for instance, mimics a normal meal and probes the integrity of the gut--liver--kidney axis. This protein challenge tests glomerular as well as tubular function. Confirmation of an increasing GFR after a stimulus is meaningful. It implies an associated decrease of RVR. To accomplish this, the kidneys' vascular reactivity as well as a critical number of pre-glomerular arterioles must be preserved.

This dynamic test of a vital organ, shows analogies with stress tests in other clinical domains. Preservation of a renal haemodynamic and/or metabolic response might imply overall vascular health to overcome planned or unintentional injurious events.

With the available evidence, measurement of the renal functional response remains restricted to research purposes. Without prospective studies delivering reference data and acknowledging that renal iconographic and biomarker research is moving at great speed, a requiem rather than a revival for renal function testing is equally possible.
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[^1]: Renal functional response = stimulated GFR -- baseline GFR (either in mL/min or in percentage of baseline GFR), i.e. renal functional reserve, renal reserve capacity, renal reserve filtration capacity.

[^2]: PO, by mouth; IV, intravenous.

[^3]: IOTH 1 (^125^I-iothalamate): IV bolus followed by a continuous infusion. Urinary and plasma clearances (to correct for incomplete voiding). HPLC measurement (in later studies); IOTH 2 (^125^I-iothalamate): single subcutaneous injection. Plasma clearances. Gamma counter measurement; IOH 1 (iohexol): IV bolus followed by a continuous infusion. Plasma clearances. HPLC measurement; EDTA 1 (^51^Cr-EDTA): IV bolus followed by a continuous infusion. Urinary clearances; EDTA 2 (^51^Cr-EDTA): single IV bolus. Plasma clearances; DTPA 1 (^99m^Tc-DTPA): single IV bolus. Plasma clearances. BSA, body surface area; HPLC, high-performance liquid chromatography; IV, intravenous; NGAL, neutrophil gelatinase-associated lipocalin.

[^4]: IOTH 1 (^125^I-iothalamate): IV bolus followed by a continuous infusion. Urinary and plasma clearances (to correct for incomplete voiding). HPLC measurement (in later studies);IOTH 2 (^125^I-iothalamate): single SC injection. Plasma clearances. Gamma counter measurement; IOH 1 (iohexol): IV bolus followed by a continuous infusion. Plasma clearances. HPLC measurement; IOH 2 (iohexol): single IV bolus. Plasma clearances. HPLC measurement; EDTA 1 (^51^Cr-EDTA): IV bolus followed by a continuous infusion. Urinary clearances; EDTA 2 (^51^Cr-EDTA): single IV bolus. Plasma clearances; DTPA 1 (^99m^Tc-DTPA): single IV bolus. Plasma clearances; DTPA 2 (^99m^Tc-DTPA): single IV bolus. Isotope renography; MAG 3 (^99m^Tc MAG 3): single IV bolus. Isotope renography; THIO (thiosulfate sodium): IV bolus followed by a continuous infusion. Urinary clearances. Measurement by the method of Brun. GN: glomerulonephritis; HUS, Haemolytic uraemic syndrome.

[^5]: IV, intravenous.

[^6]: COPD, chronic obstructive pulmonary disease; OSAS, obstructive sleep apnoea syndrome.
